Dr. David Sinclair

Genetics Researcher

David Sinclair, Ph.D., A.O. is a professor of genetics at Harvard Medical School and co-director of the Paul F. Glenn Center for Biology of Aging Research at Harvard. He is also a professor at the University of New South Wales in Sydney and co-founder of several biotechnology companies. Dr. Sinclair obtained his Ph.D. from the University of New South Wales and completed postdoctoral research at MIT. His groundbreaking research focuses on the epigenetic mechanisms of aging and the development of interventions to slow, stop, or reverse aging. He is best known for his work on sirtuins, NAD+ metabolism, and resveratrol. His laboratory was first to identify a role for NAD+ biosynthesis in regulation of lifespan and first to show that raising NAD+ levels can treat age-related diseases. Dr. Sinclair has published over 200 scientific papers, holds over 50 patents, and has received numerous awards including the Australian Medical Research Medal and TIME's list of the '100 most influential people in the world.' His book 'Lifespan' presents his Information Theory of Aging and practical strategies for extending healthspan. He continues to push the boundaries of aging research while maintaining an active public presence to educate about longevity science.